Nutrigenomic approaches for benefit-risk analysis of foods and food components:defining markers of health

R. Elliott, C. Pico, Y.E.M. Dommels, I. Wybranska, J. Hesketh, J. Keijer

Research output: Contribution to journalArticleAcademicpeer-review

36 Citations (Scopus)

Abstract

To be able to perform a comprehensive and rigorous benefit-risk analysis of individual food components, and of foods, a number of fundamental questions need to be addressed first. These include whether it is feasible to detect all relevant biological effects of foods and individual food components, how such effects can confidently be categorised into benefits and risks in relation to health and, for that matter, how health can be quantified. This article examines the last of these issues, focusing upon concepts for the development of new biomarkers of health. Clearly, there is scope for refinement of classical biomarkers so that they may be used to detect even earlier signs of disease, but this approach defines health solely as the absence of detectable disease or disease risk. We suggest that the health of a biological system may better be reflected by its ability to withstand and manage relevant physiological challenges so that homeostasis is maintained. We discuss the potential for expanding the range of current challenge tests for use in conjunction with functional genomic technologies to develop new types of biomarkers of health.
Original languageEnglish
Pages (from-to)1095-1100
JournalBritish Journal of Nutrition
Volume98
Issue number6
DOIs
Publication statusPublished - 2007

Fingerprint

Nutrigenomics
Food Analysis
Food
Health
Biomarkers
Homeostasis
Technology

Keywords

  • gene set enrichment
  • caloric restriction
  • expression profiles
  • human blood
  • transcriptome
  • humans
  • microarray
  • responses
  • pathways
  • protein

Cite this

Elliott, R. ; Pico, C. ; Dommels, Y.E.M. ; Wybranska, I. ; Hesketh, J. ; Keijer, J. / Nutrigenomic approaches for benefit-risk analysis of foods and food components:defining markers of health. In: British Journal of Nutrition. 2007 ; Vol. 98, No. 6. pp. 1095-1100.
@article{4f2a79acea90484eb4e58a8cf13276f4,
title = "Nutrigenomic approaches for benefit-risk analysis of foods and food components:defining markers of health",
abstract = "To be able to perform a comprehensive and rigorous benefit-risk analysis of individual food components, and of foods, a number of fundamental questions need to be addressed first. These include whether it is feasible to detect all relevant biological effects of foods and individual food components, how such effects can confidently be categorised into benefits and risks in relation to health and, for that matter, how health can be quantified. This article examines the last of these issues, focusing upon concepts for the development of new biomarkers of health. Clearly, there is scope for refinement of classical biomarkers so that they may be used to detect even earlier signs of disease, but this approach defines health solely as the absence of detectable disease or disease risk. We suggest that the health of a biological system may better be reflected by its ability to withstand and manage relevant physiological challenges so that homeostasis is maintained. We discuss the potential for expanding the range of current challenge tests for use in conjunction with functional genomic technologies to develop new types of biomarkers of health.",
keywords = "gene set enrichment, caloric restriction, expression profiles, human blood, transcriptome, humans, microarray, responses, pathways, protein",
author = "R. Elliott and C. Pico and Y.E.M. Dommels and I. Wybranska and J. Hesketh and J. Keijer",
year = "2007",
doi = "10.1017/S0007114507803400",
language = "English",
volume = "98",
pages = "1095--1100",
journal = "The British journal of nutrition",
issn = "0007-1145",
publisher = "Cambridge University Press",
number = "6",

}

Nutrigenomic approaches for benefit-risk analysis of foods and food components:defining markers of health. / Elliott, R.; Pico, C.; Dommels, Y.E.M.; Wybranska, I.; Hesketh, J.; Keijer, J.

In: British Journal of Nutrition, Vol. 98, No. 6, 2007, p. 1095-1100.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Nutrigenomic approaches for benefit-risk analysis of foods and food components:defining markers of health

AU - Elliott, R.

AU - Pico, C.

AU - Dommels, Y.E.M.

AU - Wybranska, I.

AU - Hesketh, J.

AU - Keijer, J.

PY - 2007

Y1 - 2007

N2 - To be able to perform a comprehensive and rigorous benefit-risk analysis of individual food components, and of foods, a number of fundamental questions need to be addressed first. These include whether it is feasible to detect all relevant biological effects of foods and individual food components, how such effects can confidently be categorised into benefits and risks in relation to health and, for that matter, how health can be quantified. This article examines the last of these issues, focusing upon concepts for the development of new biomarkers of health. Clearly, there is scope for refinement of classical biomarkers so that they may be used to detect even earlier signs of disease, but this approach defines health solely as the absence of detectable disease or disease risk. We suggest that the health of a biological system may better be reflected by its ability to withstand and manage relevant physiological challenges so that homeostasis is maintained. We discuss the potential for expanding the range of current challenge tests for use in conjunction with functional genomic technologies to develop new types of biomarkers of health.

AB - To be able to perform a comprehensive and rigorous benefit-risk analysis of individual food components, and of foods, a number of fundamental questions need to be addressed first. These include whether it is feasible to detect all relevant biological effects of foods and individual food components, how such effects can confidently be categorised into benefits and risks in relation to health and, for that matter, how health can be quantified. This article examines the last of these issues, focusing upon concepts for the development of new biomarkers of health. Clearly, there is scope for refinement of classical biomarkers so that they may be used to detect even earlier signs of disease, but this approach defines health solely as the absence of detectable disease or disease risk. We suggest that the health of a biological system may better be reflected by its ability to withstand and manage relevant physiological challenges so that homeostasis is maintained. We discuss the potential for expanding the range of current challenge tests for use in conjunction with functional genomic technologies to develop new types of biomarkers of health.

KW - gene set enrichment

KW - caloric restriction

KW - expression profiles

KW - human blood

KW - transcriptome

KW - humans

KW - microarray

KW - responses

KW - pathways

KW - protein

U2 - 10.1017/S0007114507803400

DO - 10.1017/S0007114507803400

M3 - Article

VL - 98

SP - 1095

EP - 1100

JO - The British journal of nutrition

JF - The British journal of nutrition

SN - 0007-1145

IS - 6

ER -